Bioworkshop
Biotechnology, 100 Rawson Rd, , New York, new York, 14564, United States, 1-10 Employees
Phone Number: +14*********
Who is BIOWORKSHOP
At Bioworkshop, we are developing a full-stack drug discovery & development platform that will make drug R& more efficient and accurate. Combining the power of in silico discovery and scr...
Read More
- Headquarters: 100 Rawson Rd, new York, New York, 14564, United States
- Date Founded: 2019
- Employees: 1-10
- Revenue: $50 Million to $100 Million
- Active Tech Stack: See technologies
- CEO: Amel Ibrahim
Industry: Biotechnology
SIC Code: 2879 | NAICS Code: 561990 | Show More
Does something look wrong? Fix it. | View contact records from BIOWORKSHOP
Bioworkshop Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Bioworkshop
Answer: Bioworkshop's headquarters are located at 100 Rawson Rd, , New York, new York, 14564, United States
Answer: Bioworkshop's phone number is +14*********
Answer: Bioworkshop's official website is https://thebioworkshop.com
Answer: Bioworkshop's revenue is $50 Million to $100 Million
Answer: Bioworkshop's SIC: 2879
Answer: Bioworkshop's NAICS: 561990
Answer: Bioworkshop has 1-10 employees
Answer: Bioworkshop is in Biotechnology
Answer: Bioworkshop contact info: Phone number: +14********* Website: https://thebioworkshop.com
Answer: At Bioworkshop, we are developing a full-stack drug discovery & development platform that will make drug R& more efficient and accurate. Combining the power of in silico discovery and screening with more accurate in vitro pre-clinical validation on high-fidelity human models, our platform offers faster and more accurate lead identification and optimization. Data from each stage of our process is used to reinforce learning and improve our models. Our end-to-end drug discovery and development platform allows rapid in silico screening of potential drug candidates and biological targets using extensive knowledge maps and machine learning tools. We then use high-fidelity human models to conduct in vitro pre-clinical testing of leads, providing more accurate and clinically relevant results than traditional methods. This allows us to better predict how potential drug candidates will behave in humans and identify any potential safety concerns early on in the drug development process. Our initial focus is on age-related disorders, which are a growing concern for the global population. These disorders include wound healing, skin ageing, melanoma, atopy, Parkinsons disease and osteoarthritis, all of which can have a significant impact on quality of life and global healthcare costs. By focusing on these areas, we hope to make a real difference in the lives of millions of people around the world.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month